Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-03

Clinical Trial Update: rTMS for MDD: 5.5cm Rule vs. F3 Targeting [NA]

View source ↗

Summary

Completed study comparing 5.5 cm rule versus F3 targeting for repetitive transcranial magnetic stimulation (rTMS) in major depressive disorder, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Nicholas Trapp | Conditions: Major Depressive Disorder, Depression | NA | Status: COMPLETED | Results posted: 2025-02-03